Literature DB >> 17016142

Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice.

Gianluigi Giannelli1, Salvatore Antonaci.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, burdened by a constantly increasing frequency. Therapy is currently restricted to invasive techniques but prognosis and survival are still unsatisfactory, mainly because of HCC recurrence and metastasis diffusion. This review will focus on the problem of tumor recurrence and/or metastasis, pointing out the role of the tissue microenvironment in affecting HCC behavior; new experimental findings will also be discussed in the light of their implications in medical care. Finally, new therapeutic approaches will be considered, paying particular attention to the tissue microenvironment as a potential target. In conclusion, this review will attempt to stimulate debate on translational research into HCC biology, in the field of clinical applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016142     DOI: 10.1097/01.mcg.0000225543.11503.17

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.

Authors:  Jiarui Jiang; Guoqing Liu; Xiongying Miao; Songwen Hua; Dewu Zhong
Journal:  Exp Ther Med       Date:  2011-03-18       Impact factor: 2.447

2.  Surgical resection versus open-approach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization.

Authors:  Jianyong Lei; Wentao Wang; Lunan Yan
Journal:  J Gastrointest Surg       Date:  2013-10       Impact factor: 3.452

3.  Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma.

Authors:  Zhi Xu; Chunxiang Cao; Haiyan Xia; Shujing Shi; Lingzhi Hong; Xiaowei Wei; Dongying Gu; Jianmin Bian; Zijun Liu; Wenbin Huang; Yixin Zhang; Song He; Nikki Pui-Yue Lee; Jinfei Chen
Journal:  Front Med       Date:  2016-01-25       Impact factor: 4.592

4.  Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Authors:  Jing-jing Zhao; Ke Pan; Jian-jun Li; Yi-bing Chen; Ju-gao Chen; Lin Lv; Dan-dan Wang; Qiu-zhong Pan; Min-shan Chen; Jian-chuan Xia
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

5.  The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Authors:  Wenfeng Liu; Feng Zhang; Bing Quan; Miao Li; Shenxin Lu; Jinghuan Li; Rongxin Chen; Xin Yin
Journal:  Dis Markers       Date:  2021-11-19       Impact factor: 3.434

6.  Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Authors:  Ke Hao; John M Luk; Nikki P Y Lee; Mao Mao; Chunsheng Zhang; Mark D Ferguson; John Lamb; Hongyue Dai; Irene O Ng; Pak C Sham; Ronnie T P Poon
Journal:  BMC Cancer       Date:  2009-11-03       Impact factor: 4.430

7.  Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.

Authors:  Murat Cokakli; Esra Erdal; Deniz Nart; Funda Yilmaz; Ozgul Sagol; Murat Kilic; Sedat Karademir; Nese Atabey
Journal:  BMC Cancer       Date:  2009-02-24       Impact factor: 4.430

8.  Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.

Authors:  Jing-Jing Zhao; Qiu-Zhong Pan; Ke Pan; De-Sheng Weng; Qi-Jing Wang; Jian-Jun Li; Lin Lv; Dan-Dan Wang; Hai-Xia Zheng; Shan-Shan Jiang; Xiao-Fei Zhang; Jian-Chuan Xia
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.